John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 69,530 shares at $136.86 ($9.5M) on 2020-08-20, disclosed to the SEC on 2020-08-21.
Open-market sale of $9.5M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.09 | 4,775 | $645K | 6.8% |
| 2 | $135.09 | 4,775 | $645K | 6.8% |
| 3 | $136.07 | 21,448 | $2.9M | 30.8% |
| 4 | $136.07 | 21,448 | $2.9M | 30.8% |
| 5 | $136.86 | 8,542 | $1.2M | 12.4% |
| 6 | $136.86 | 8,542 |
| $1.2M |
| 12.4% |
| Total | $136.13 avg | 69,530 | $9.5M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |